97 related articles for article (PubMed ID: 12385857)
21. Utilisation of hormone replacement therapy in the United Kingdom. A descriptive study using the general practice research database.
Bromley SE; de Vries CS; Farmer RD
BJOG; 2004 Apr; 111(4):369-76. PubMed ID: 15008775
[TBL] [Abstract][Full Text] [Related]
22. Hormone replacement therapy and accuracy of mammographic screening.
Kavanagh AM; Mitchell H; Giles GG
Lancet; 2000 Jan; 355(9200):270-4. PubMed ID: 10675074
[TBL] [Abstract][Full Text] [Related]
23. Hormone replacement therapy and previous use of oral contraceptives among Swedish women.
Hammar M; Brynhildsen J; Dabrosin L; Frisk J; Lindgren R; Nedstrand E; Wyon Y
Maturitas; 1996 Nov; 25(3):193-9. PubMed ID: 8981336
[TBL] [Abstract][Full Text] [Related]
24. Use of hormone replacement therapy by postmenopausal women in the United States.
Keating NL; Cleary PD; Rossi AS; Zaslavsky AM; Ayanian JZ
Ann Intern Med; 1999 Apr; 130(7):545-53. PubMed ID: 10189323
[TBL] [Abstract][Full Text] [Related]
25. Hormone replacement therapy and symptom reporting in menopausal women: a population-based study of 35-65-year-old women in mid-Sweden.
Bardel A; Wallander MA; Svärdsudd K
Maturitas; 2002 Jan; 41(1):7-15. PubMed ID: 11809338
[TBL] [Abstract][Full Text] [Related]
26. Hormone replacement therapy and increased plasma concentration of C-reactive protein.
Ridker PM; Hennekens CH; Rifai N; Buring JE; Manson JE
Circulation; 1999 Aug; 100(7):713-6. PubMed ID: 10449692
[TBL] [Abstract][Full Text] [Related]
27. Ascorbic acid status in postmenopausal women with hormone replacement therapy.
Kuo SM; Stout A; Wactawski-Wende J; Leppert PC
Maturitas; 2002 Jan; 41(1):45-50. PubMed ID: 11809342
[TBL] [Abstract][Full Text] [Related]
28. What factors account for hormone replacement therapy prescribing frequency?
Newton KM; LaCroix AZ; Buist DS; Anderson LA; Delaney K
Maturitas; 2001 Jul; 39(1):1-10. PubMed ID: 11451615
[TBL] [Abstract][Full Text] [Related]
29. Hormone replacement therapy and health behavior in postmenopausal polio survivors.
Kalpakjian CZ; Riley BB; Quint EH; Tate DG
Maturitas; 2004 Aug; 48(4):398-410. PubMed ID: 15283932
[TBL] [Abstract][Full Text] [Related]
30. The influence of hormone replacement therapy (HRT) on serum leptin concentration in postmenopausal women.
Hadji P; Görke K; Hars O; Bauer T; Emons G; Schulz KD
Maturitas; 2000 Dec; 37(2):105-11. PubMed ID: 11137329
[TBL] [Abstract][Full Text] [Related]
31. Correlates of hormone replacement therapy use in Italian women, 1992-1996.
Chiaffarino F; Parazzini F; La Vecchia C; Bianchi MM; Benzi G; Ricci E; Chiantera V
Maturitas; 1999 Oct; 33(2):107-15. PubMed ID: 10597874
[TBL] [Abstract][Full Text] [Related]
32. Breast cancer risk factors in Queensland women attending population-based mammography screening.
Protani M; Page A; Taylor R; Glazebrook R; Lahmann PH; Branch E; Muller J
Maturitas; 2012 Mar; 71(3):279-86. PubMed ID: 22225652
[TBL] [Abstract][Full Text] [Related]
33. Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality.
O'Meara ES; Rossing MA; Daling JR; Elmore JG; Barlow WE; Weiss NS
J Natl Cancer Inst; 2001 May; 93(10):754-62. PubMed ID: 11353785
[TBL] [Abstract][Full Text] [Related]
34. Use of multiple providers for regular care and women's receipt of hormone replacement therapy counseling.
Gallagher TC; Geling O; Comite F
Med Care; 2001 Oct; 39(10):1086-96. PubMed ID: 11567171
[TBL] [Abstract][Full Text] [Related]
35. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
[TBL] [Abstract][Full Text] [Related]
36. Factors predicting current use of hormone replacement therapy among menopausal Jewish women in Israel. The National Women's Health Interview Survey, 1998.
Merom D; Ifrah A; Cohen-Manheim I; Chinich A; Green MS
Isr Med Assoc J; 2002 Sep; 4(9):671-6. PubMed ID: 12440227
[TBL] [Abstract][Full Text] [Related]
37. Are long-term hormone replacement therapy users different from short-term and never users?
Buist DS; LaCroix AZ; Newton KM; Keenan NL
Am J Epidemiol; 1999 Feb; 149(3):275-81. PubMed ID: 9927224
[TBL] [Abstract][Full Text] [Related]
38. Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years.
Daling JR; Malone KE; Doody DR; Voigt LF; Bernstein L; Marchbanks PA; Coates RJ; Norman SA; Weiss LK; Ursin G; Burkman RT; Deapen D; Folger SG; McDonald JA; Simon MS; Strom BL; Spirtas R
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1175-81. PubMed ID: 14652277
[TBL] [Abstract][Full Text] [Related]
39. Life prevalence of hormone replacement therapy and profile of users have not changed among women with self-reported menopause in the last two decades in Porto, Portugal.
Lucas R; Barros H
Climacteric; 2008 Feb; 11(1):26-31. PubMed ID: 18202962
[TBL] [Abstract][Full Text] [Related]
40. Effects of postmenopausal hormone replacement therapy on body fat composition.
Yüksel H; Odabasi AR; Demircan S; Köseoğlu K; Kizilkaya K; Onur E
Gynecol Endocrinol; 2007 Feb; 23(2):99-104. PubMed ID: 17454160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
